Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
scm-010 (1 trial)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Chronic Progressive (Phase 2)
Neoplasm Metastasis (Phase 2)
Sclerosis (Phase 2)
Trials (1 total)
Trial APIs (1 total)